These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 32328476)

  • 1. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
    Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
    Front Chem; 2020; 8():167. PubMed ID: 32328476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.
    Sahin K; Zengin Kurt B; Sonmez F; Durdagi S
    J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid
    Sahin K; Orhan MD; Avsar T; Durdagi S
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1111-1123. PubMed ID: 34151203
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Sahin K
    J Biomol Struct Dyn; 2022 Feb; 40(3):1152-1162. PubMed ID: 33016840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target.
    Ikram S; Ahmad J; Durdagi S
    J Mol Graph Model; 2020 Mar; 95():107462. PubMed ID: 31786094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Re-positioning Studies for Novel HIV-1 Inhibitors Using Binary QSAR Models and Multi-target-driven In Silico Studies.
    Dogan B; Durdagi S
    Mol Inform; 2021 Feb; 40(2):e2000012. PubMed ID: 33405326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.
    Şahİn K; DurdaĞi S
    Turk J Chem; 2020; 44(3):574-588. PubMed ID: 33488178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.
    Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Ghosh A; Chaudhari S; Khatale PN; Ajmire P; Jawarkar RD
    Front Pharmacol; 2023; 14():1129997. PubMed ID: 37144217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposing novel MDM2 inhibitors: Combined physics-driven high-throughput virtual screening and in vitro studies.
    Aydin G; Paksoy MN; Orhan MD; Avsar T; Yurtsever M; Durdagi S
    Chem Biol Drug Des; 2020 Jul; 96(1):684-700. PubMed ID: 32691963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease.
    Oktay L; Erdemoğlu E; Tolu İ; Yumak Y; Özcan A; Acar E; Büyükkiliç Ş; Olkan A; Durdaği S
    Turk J Biol; 2021; 45(4):459-468. PubMed ID: 34803447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of novel indole-based HIV-1 protease inhibitors using virtual screening and text mining.
    Sahin K
    J Biomol Struct Dyn; 2021 Jul; 39(10):3638-3648. PubMed ID: 32496942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
    Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
    Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening.
    Sirous H; Campiani G; Calderone V; Brogi S
    Comput Biol Med; 2021 Oct; 137():104808. PubMed ID: 34478925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
    Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
    J Mol Graph Model; 2017 Oct; 77():338. PubMed ID: 28957754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.